Literature DB >> 8584987

Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?

B P Koeleman1, D van Rumpt, K Hamulyák, P H Reitsma, R M Bertina.   

Abstract

We recently reported a high prevalence of the FV Leiden mutation (R506Q, responsible for Activated Protein C resistance) among symptomatic protein C deficient probands (19%), and the involvement of the FV Leiden mutation in the expression of thrombophilia in six protein C deficient families. Here, we report the results of a similar study in protein S deficient probands and families. Among 16 symptomatic protein S deficient probands the prevalence of the FV Leiden mutation was high (38%). This high prevalence is significantly different from that in the normal population, and is probably caused by the selection of probands for familial thrombosis and protein S deficiency. In 4 families, the segregation of the FV Leiden mutation and the protein S deficiency could be studied. In sibships where both abnormalities were segregating, the percentage of symptomatic individuals with both abnormalities was 80%. Three of the seven subjects with only the FV Leiden mutation, and two out of the three subjects with only protein S deficiency had developed thrombosis. These results indicate that in the families presented here the combination of the FV Leiden mutation and the protein S deficiency is associated with a high risk for thrombosis. A reliable estimate of the penetrance of the single defects is not possible, because the number of individuals with a single defect is too low.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584987

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Evaluation of Hypercoagulable States.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

2.  Mesenteric venous thrombosis causing jejunal stricture: secondary to hypercoagulable states and primary portal hypertension.

Authors:  S Chandra; U Dutta; R Das; K Vaiphei; B Nagi; K Singh
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

3.  Postmortem diagnosis of Factor V Leiden from paraffin wax embedded tissue.

Authors:  J S Webb; G R Standen; C M Collins; C P Case
Journal:  Clin Mol Pathol       Date:  1996-06

Review 4.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

Review 5.  Delineating the Hemostaseome as an aid to individualize the analysis of the hereditary basis of thrombotic and bleeding disorders.

Authors:  Kim Fechtel; Marika L Osterbur; Hildegard Kehrer-Sawatzki; Peter D Stenson; David N Cooper
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

6.  An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency.

Authors:  S J Hasstedt; E G Bovill; P W Callas; G L Long
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

7.  Hereditary thrombophilia.

Authors:  Salwa Khan; Joseph D Dickerman
Journal:  Thromb J       Date:  2006-09-12

Review 8.  Clotting disorder in severe acute respiratory syndrome coronavirus 2.

Authors:  Sujit Pujhari; Sanjeeta Paul; Jasmina Ahluwalia; Jason L Rasgon
Journal:  Rev Med Virol       Date:  2020-10-06       Impact factor: 11.043

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.